UCB posts more supportive data from Humira rival bimekizumab

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 6, 2019 at 9:52 PM.

  1. #1 cafead, Dec 6, 2019 at 9:52 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,033
    Likes Received:
    3
    via There’s a whole gang of pharma companies queueing up to steal market share from AbbVie’s mega-blockbuster Humira, and UCB’s contender bimekizumab is shaping up for a challenge with another set of supportive trial data in psoriasis.

    article source
     
    Quote

Reply to Thread